The content on this page is designed for Europe. Check courses designed for Canada (EN)

This course has expired. View available courses.

Endocrinology

Intensifying Therapy: Primary Care Patient Case (RCGP)

Type 2 diabetes is a common condition managed in primary care. Although clinical practice guidelines recommend specific targets for blood pressure, lipids and HbA1c, primary care research has demonstrated only a small portion of patients with type 2 diabetes are meeting these targets. With the management of type diabetes, clinicians are still encouraged to work with patients to meet glycaemic targets, but there is an increased focus on a holistic assessment of the patient to reduce the risk of cardiorenal outcomes. This module will focus on providing recommendations on the intensification of antihyperglycaemic therapy beyond metformin in people with type 2 diabetes.

This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A/S.

DURATION

30 min

PROFESSION

Physician, Nursing, Student, Specialist

# OF CREDITS

0.5

ACCREDITATION

RCGP

EXPIRY DATE

2023-03-07

Type 2 diabetes is a common condition managed in primary care. Although clinical practice guidelines recommend specific targets for blood pressure, lipids and HbA1c, primary care research has demonstrated only a small portion of patients with type 2 diabetes are meeting these targets. With the management of type diabetes, clinicians are still encouraged to work with patients to meet glycaemic targets, but there is an increased focus on a holistic assessment of the patient to reduce the risk of cardiorenal outcomes. This module will focus on providing recommendations on the intensification of antihyperglycaemic therapy beyond metformin in people with type 2 diabetes.


This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A/S.

Faculty

Dirk Pilat, FRCGP, PgDipGP, BSc, MA
David Strain, MD, FRCP, MBChB
Toni Hazell, MBBS, BSc, MRCGP, DFSRH, Dip GU med, DRCOG, DCH

Learning objectives

Upon successful completion of this continuing education module, the participant will be better able to:

  1. Individualize antihyperglycaemic therapy for the person with type 2 diabetes
  2. Review how the most recently published antihyperglycaemic agent trials are potentially changing the management of people with type 2 diabetes
  3. Discuss the selection of antihyperglycaemic agents in patients with cardiovascular and chronic kidney disease

Accreditation

RCGP Accreditation has been officially approved. Time taken to complete this course will depend on a variety of factors including previous experience of the subject. CPD time should be claimed according to the actual time taken on the course including any reflections made and quality improvement activities arising from the course.
Cost of course:  
Free
# of credits: 0.5
Duration: 30 min

FAQs & HELP

MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.

All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.

The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

No, registration with MDBriefCase is free!

To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.

If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.

Please note: if you submitted multiple password resets, only the link on the most recent email is valid.

You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.